Skip to main content

Published locations for ODYSSEY: Alirocumab improves lipids but not glycemic targets in 2DM

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ODYSSEY: Alirocumab improves lipids but not glycemic targets in 2DM

User login

  • Reset your password
  • /content/odyssey-alirocumab-improves-lipids-not-glycemic-targets-2dm
  • /familypracticenews/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic-targets
  • /internalmedicinenews/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic-targets
  • /vascularspecialistonline/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic
  • /clinicalendocrinologynews/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic
  • /ecardiologynews/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic-targets-2dm
  • /cardiology/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic-targets-2dm
  • /endocrinology/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic-targets-2dm
  • /internalmedicine/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic-targets-2dm
  • /familymedicine/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic-targets-2dm
  • /type-2-diabetes-icymi/article/140830/diabetes/odyssey-alirocumab-improves-lipids-not-glycemic